- Home
- QTRX vs ENLV Comparison
QTRX vs ENLV Comparison
Compare QTRX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QTRX | ENLV |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.0M | 249.3M |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | QTRX | ENLV |
|---|---|---|
| Price | $6.36 | $1.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $11.33 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 793.2K | 464.3K |
| Earning Date | 03-16-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $130,203,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.05 | $0.66 |
| 52 Week High | $9.10 | $2.10 |
Technical Indicators
Market Signals| Indicator | QTRX | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 55.83 |
| Support Level | $6.29 | $0.99 |
| Resistance Level | $6.85 | $1.26 |
| Average True Range (ATR) | 0.50 | 0.08 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 14.46 | 41.76 |
Price Performance
Historical ComparisonAbout QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.